Dr Reddy's CEO Erez Israeli expects a healthy performance in the second half of FY2026-27 once the company resolves the semaglutide issue. Israeli believes the generics market for semaglutide in will be ultra-competitive, with more than 20 companies trying to gain market share.
ADNOC Drilling reported profit for the second quarter that beat estimates. Profits rose 1.7% Y/Y to $357.1 million while revenue grew by 2.9%. Abdulla Ateya Al Messabi, ADNOC Drilling's CEO spoke to Bloomberg's Abeer Abu Omar on the performance as well as future plans for the company.
The CEO of Schneider Electric says the strategy is to grow organically as much as possible, but could also find new tech companies to accelerate the expansion strategy. Olivier Blum also sees fast growth in data centers in China. He spoke exclusively with Bloomberg's Lizzy Burden from Paris.
The world's largest outdoor advertising company JCDecaux had a 'very good first half' and the impact of the war in the Middle East was 'less than expected', according to the company's Co-CEO. Jean-Francois Decaux spoke exclusively with Bloomberg's Lizzy Burden from Paris.
Ken Wong, Asian Equity Portfolio Specialist at Eastspring Investments, breaks down where investors can find opportunities amid an on-and-off selloff in AI-related equities, pointing to electronic component companies as a strong contender.
Hans Patuwo, CEO of GoTo Group, discusses the Indonesian ride-hailing and food delivery firm's 2Q results, marking a consecutive quarter of net income. He outlines the company's outlook and addresses its stock price, which has hovered at the lowest level permitted for regular trading under Jakarta exchange rules. He speaks with Haidi Stroud Watts on "Bloomberg: The Asia Trade".
Airbus is on track for its delivery targets and looking into smaller defense deals in its M&A efforts, CFO Thomas Toepfer tells Bloomberg's Romaine Bostick.
Samsung Electronics Co.'s semiconductor arm reported a more than 250-fold jump in profit, with an operating income of 89.2 trillion won in the June quarter. Bloomberg's Anthony Stephens reports on the latest data.
Federal Reserve Chairman Kevin Warsh has said the decision to leave interest rates unchanged wasn't a sign of inertia at the central bank, which is committed to tackling inflation. Brown University Professor of International Economics Sebnem Kalemli-Ozcan breaks down how markets are interpreting the signals.
Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE.
